Actively Recruiting
Remote Feasibility Trial Evaluating Phenylbutyrate Treatment for SLC6A1-Related Disorders
Led by Scripps Translational Science Institute · Updated on 2026-09-29
20
Participants Needed
1
Research Sites
187 weeks
Total Duration
AI-Summary
What This Trial Is About
This trial investigates the feasibility of conducting a fully remote clinical study for individuals with SLC6A1-related disorders, a rare genetic condition causing epilepsy and intellectual disability. It aims to evaluate phenylbutyrate, a medication approved for other conditions, for its potential to reduce seizures and improve symptoms in this population. The study also explores the safety and tolerability of phenylbutyrate and tests whether remote trial methods work well for families living anywhere in the U.S. Participants are randomly assigned to one of two groups one begins phenylbutyrate treatment immediately for up to 18 weeks, while the other undergoes a 6-week observation period before starting treatment. The drug is given orally three times daily, with doses gradually increased over 8 weeks based on body surface area and safety lab results. After the initial treatment period, participants may choose to extend treatment for up to 3 years, with follow-up visits scheduled at 18 weeks, 6 months, 1 year, and annually thereafter. Throughout the study, caregivers report seizure frequency and side effects and complete questionnaires. Electroencephalograms EEG, lab tests, and safety monitoring are performed remotely. Researchers assess recruitment, adherence to study procedures, and caregiver satisfaction, along with changes in seizure frequency, behavior, and quality of life. Participation is voluntary, with risks including possible adverse effects and data confidentiality concerns. No physical visits are required, making the study accessible to families across the U.S.
CONDITIONS
Brief Title
A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders
Research Team
K
Kristen Barbour, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here